On Monday, Citi adjusted its price target for Bunge Limited (NYSE:BG), a global agribusiness and food company, reducing it to $96.00 from the previous $114.00. Despite this change, the firm maintained a Neutral rating on the company's shares. The revision comes ahead of Bunge's scheduled third-quarter earnings report on October 30, 2024.
Citi anticipates that Bunge is likely to surpass earnings expectations for the third quarter and may enhance its outlook for the year 2024, potentially leading to higher estimates for fourth-quarter earnings per share (EPS). The expected increase in EPS projections is attributed to improving oilseed crush margins, which could influence the stock positively, especially given the current high level of short interest in Bunge shares.
Despite the possibility of a strong third-quarter performance and an improved forecast for the fourth quarter, Citi does not foresee this positively impacting investor concerns regarding Bunge's earnings for 2025 and the years that follow. The firm's stance indicates caution regarding the company's longer-term earnings potential, even in the face of potential short-term gains.
Bunge's upcoming earnings report will be closely watched by investors, as it will provide further insight into the company's financial health and its ability to navigate the market dynamics affecting the agribusiness sector. The market will also be looking to see if the company's performance aligns with Citi's predictions of a likely earnings beat and an optimistic outlook for the near term.
In other recent news, Bunge Global SA has finalized the sale of its 50% stake in BP (NYSE:BP) Bunge Bioenergia to bp, allowing bp to fully own the joint venture. This step aligns with Bunge's strategy to streamline its portfolio and focus on core agribusiness operations.
Simultaneously, the company has initiated exchange offers for Viterra Limited's outstanding notes, totaling $1.95 billion, about their pending acquisition. This move is expected to enhance Bunge's global scale in the agribusiness sector.
On the earnings front, Bunge reported a robust adjusted EBIT for the second quarter of 2024 and updated its full-year adjusted EPS forecast to approximately $9.25.
In other developments, Bunge and Archer-Daniels-Midland Co. are expecting increased profitability due to a surge in crop sales by U.S. farmers. This could provide cheaper soybean ownership for both companies and help them utilize any excess manufacturing capacity. Despite a drop in second-quarter agribusiness earnings, Bunge has raised its full-year outlook.
These are the recent developments in the company.
InvestingPro Insights
In light of Citi's recent price target adjustment for Bunge Limited (NYSE:BG), it's worth considering some additional financial metrics and insights from InvestingPro. Despite the lowered price target, Bunge's current P/E ratio of 10.87 suggests the stock is trading at a relatively low earnings multiple. This valuation metric aligns with one of the InvestingPro Tips, which notes that Bunge is "Trading at a low earnings multiple."
Another relevant InvestingPro Tip highlights that Bunge "Has maintained dividend payments for 24 consecutive years," indicating a strong commitment to shareholder returns. This is further supported by the company's current dividend yield of 2.77% and a dividend growth rate of 8.8% over the last twelve months.
While Citi expresses caution about Bunge's long-term earnings potential, it's noteworthy that the company has demonstrated a "Strong return over the last five years," according to InvestingPro. This historical performance, coupled with the fact that analysts predict the company will be profitable this year, may provide some counterbalance to the concerns raised about future earnings.
For investors seeking a more comprehensive analysis, InvestingPro offers 13 additional tips for Bunge, providing a deeper understanding of the company's financial position and market outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.